文献速递前列腺癌

初始前列腺健康指数(phi)及phi密度预测初次活检阴性男性未来临床显著前列腺癌风险:6年随访研究

Initial Prostate Health Index (phi) and phi density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: a 6-year follow-up study.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2021-08-27

结果显示,基线phi值较高与前列腺癌(PCa)及高级别前列腺癌(HGPCa)诊断相关,phi≥35或phi密度≥1.2者HGPCa风险显著升高,而phi<25或phi密度<0.4者风险极低。

要点

  • 基线phi≥35或phi密度≥1.2者6年内HGPCa风险显著升高,需密切随访。
  • phi<25或phi密度<0.4者HGPCa风险极低,可减少随访频率。
  • phi和phi密度可预测初次活检阴性男性未来PCa和HGPCa诊断。

核心结论

  • 在初次前列腺活检阴性的男性中,初始phi或phi密度可预测6年前列腺癌风险。

主要发现

  • 整个队列中PCa和HGPCa诊断率分别为8.2%(38/461)和4.8%(22/461)。
  • 基线phi较高与PCa(p=0.003)和HGPCa(p<0.001)诊断相关。
  • HGPCa在phi<25组为0.6%(1/163),phi 25-34.9组为4.6%(9/195),phi≥35组为11.7%(12/103)(p<0.001)。
  • HGPCa在phi密度<0.4组为0%(0/109),phi密度≥1.2组为21.0%(13/62)(p<0.001)。
  • Kaplan-Meier曲线显示phi和phi密度可预测PCa和HGPCa诊断(log-rank检验,所有p≤0.002)。

关键数值与推荐

  • phi≥35或phi密度≥1.2的男性需要更密切的随访和重复检查。
  • phi<25或phi密度<0.4的男性可减少随访频率。

临床怎么用

  • 对于初次活检阴性的男性,可根据初始phi和phi密度进行风险分层,制定个体化随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Men with elevated prostate-specific antigen (PSA) and initial negative prostate biopsy may have risk of prostate cancer (PCa) in the future. The role of Prostate Health Index (phi) in determining future PCa risk has not been studied before. This study aims to investigate the role of initial phi and phi density in predicting future PCa risk in men with initial negative biopsy. METHODS: Five hundred sixty nine men with PSA 4-10 ng/mL were recruited between 2008 and 2015 for prostate biopsy with prior phi. Electronic clinical record of men with initial negative biopsy was reviewed. Patients and follow-up doctors were blinded to phi. Kaplan-Meier curves were used to analyze the PCa-free survival in different baseline phi and phi density groups. RESULTS: Four hundred sixty-one men with complete follow-up data were included. Median follow-up is 77 months. PCa and HGPCa was diagnosed in 8.2% (38/461) and 4.8% (22/461) of cohort respectively. A higher baseline phi value was associated with PCa (p = 0.003) and HGPCa (p < 0.001). HGPCa was diagnosed in 0.6% (1/163) of phi < 25, 4.6% (9/195) of phi 25-34.9, and 11.7% (12/103) of phi ≥ 35 (p < 0.001). HGPCa was diagnosed in 0% (0/109) and 21.0% (13/62) with phi density of <0.4 and ≥1.2, respectively, (p < 0.001). Kaplan-Meier curves showed phi and phi density predicted PCa and HGPCa diagnoses (log-rank test, all p ≤ 0.002). CONCLUSIONS: Initial phi or phi density predicted 6-year risk of PCa in men with initial negative prostate biopsy. Men with higher phi (≥35) or phi density (≥1.2) need closer follow-up and repeated investigation, while men with lower phi (<25) or phi density (<0.4) could have less frequent follow-up.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Liu AQ, Remmers S, Lau SY, et al. Initial Prostate Health Index (phi) and phi density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: a 6-year follow-up study. Prostate Cancer Prostatic Dis. 2021. PMID: 34453109. doi:10.1038/s41391-021-00444-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。